NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,262,829 | +135.4% | 54,526 | +241.1% | 0.28% | +160.6% |
Q1 2023 | $961,398 | -57.7% | 15,986 | -48.4% | 0.11% | -57.9% |
Q4 2022 | $2,272,383 | +375.4% | 30,980 | +392.0% | 0.26% | +398.1% |
Q3 2022 | $478,000 | -78.4% | 6,297 | -80.2% | 0.05% | -76.1% |
Q2 2022 | $2,212,000 | +90.5% | 31,831 | +105.8% | 0.22% | +73.0% |
Q4 2021 | $1,161,000 | -38.0% | 15,466 | -4.0% | 0.13% | -11.9% |
Q3 2021 | $1,872,000 | +38.1% | 16,114 | +163.6% | 0.14% | +19.2% |
Q2 2021 | $1,356,000 | +108.0% | 6,112 | +23.9% | 0.12% | +110.5% |
Q1 2021 | $652,000 | – | 4,933 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |